Jason Amello

Insider Reports History

Location
Cambridge, MA
Signature
/s/ Zoran Zdraveski, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason Amello:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Financial Officer Common Stock 202,009 $181,808 $0.9000 28 Nov 2023 Direct
TScan Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 350,000 20 Jan 2026 Direct
Candel Therapeutics, Inc. Chief Financial Officer Stock Option (Right to Buy) 90,000 28 Apr 2023 Direct
Acer Therapeutics Inc. Director Stock Option (right to buy) 20,000 14 Mar 2023 Direct

Insider Reports Filed by Jason Amello

Symbol Company Period Transactions Value $ Form Type Role Filing Time
TCRX TScan Therapeutics, Inc. 20 Jan 2026 1 $0 4 Chief Financial Officer 22 Jan 2026, 17:52
TCRX TScan Therapeutics, Inc. 03 Jan 2025 1 $0 4 Chief Financial Officer 11 Feb 2025, 17:47
TCRX TScan Therapeutics, Inc. 01 Feb 2024 1 $0 4 Chief Financial Officer 02 Feb 2024, 16:21
TCRX TScan Therapeutics, Inc. 29 Jan 2024 0 $0 3 Chief Financial Officer 02 Feb 2024, 16:14
CADL Candel Therapeutics, Inc. 28 Nov 2023 1 -$18,138 4 Chief Financial Officer 30 Nov 2023, 17:00
CADL Candel Therapeutics, Inc. 26 Nov 2023 1 $0 4 Chief Financial Officer 28 Nov 2023, 16:30
CADL Candel Therapeutics, Inc. 28 Apr 2023 1 $0 4 Chief Financial Officer 02 May 2023, 16:45
/report/000120919123019289-amello-jason-2023-03-14 Acer Therapeutics Inc. 14 Mar 2023 1 $0 4 Director 16 Mar 2023, 16:21
CADL Candel Therapeutics, Inc. 08 Dec 2022 2 +$10,002 4 Chief Financial Officer 12 Dec 2022, 15:25
CADL Candel Therapeutics, Inc. 28 Nov 2022 1 $0 4 Chief Financial Officer 30 Nov 2022, 17:31
CADL Candel Therapeutics, Inc. 21 Sep 2022 1 $0 4 Chief Financial Officer 23 Sep 2022, 16:15
CADL Candel Therapeutics, Inc. 21 Sep 2022 0 $0 3 Chief Financial Officer 23 Sep 2022, 16:10
/report/000120919122003701-amello-jason-2022-01-14 Acer Therapeutics Inc. 14 Jan 2022 1 $0 4 Director 19 Jan 2022, 15:10